Microvention Inc.
This article was originally published in Start Up
Executive Summary
Microvention Inc., a three-year-old start-up, is developing minimally invasive devices for treating cerebral vascular conditions. Its is first focusing on developing a better devices for treating aneurysms. It has a hybrid device, combining coils with a sponge-like hydrogel material that fills the aneurysm, cutting it off from the blood vessel. This allows the blood vessel to heal and recover its full strength. The product is in pre-clinical trials.
You may also be interested in...
Neurovascular Market's Time Has Come: Stealthy Sequent Medical Unveils Strategy
With foresight, good timing, or simply years of experience, the founders of Sequent Medical (who also founded MicroVention) are launching a new endovascular product in Europe just as large companies are signalling their interest in the space via acquisitions. For the treatment of cerebral aneurysms, Sequent has developed a novel device that combines the best attributes of embolization coils and flow diverters, its founders believe.
ATV Moves West Where the Devices Are
Advanced Technology Ventures, is an example of a venture firm that got into health care investing by initially focusing on medical devices in 1986. In order to remain closely involved with device start-ups, ATV has beefed up its presence in the hub of device innovation, the San Francisco area.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.